NUVA News and Press, NuVasive Inc. From 04/11/23

2023-04-11 16:03:05 ET Following a review of Q1 expectations in its MedTech coverage, Barclays grouped Baxter International ( NYSE: BAX ), Edwards Lifesciences ( NYSE: EW ), Tandem Diabetes Care ( NASDAQ: TNDM ), and Globus Medical ( NYSE: GMED ) as its bulli...

NuVasive to Participate in Upcoming Global Spine Conferences PR Newswire SAN DIEGO , April 11, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, pro...

NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...

NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients PR Newswire SAN DIEGO , March 20, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transfo...

NEW YORK, NY / ACCESSWIRE / March 19, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ...

NuVasive to Participate in Upcoming Spine Society Annual Conferences PR Newswire SAN DIEGO , March 14, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, ...

NuVasive Celebrates 20-Year Milestone of the XLIF Procedure PR Newswire NuVasive commemorates industry-defining innovation in the lateral procedural segment SAN DIEGO , March 13, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine...

NEW YORK, NY / ACCESSWIRE / February 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ...

NuVasive, Inc. (NUVA) Q4 2022 Earnings Conference Call February 22, 2023, 16:30 ET Company Participants Juliet Cunningham - VP, IR Christopher Barry - CEO & Director Matthew Harbaugh - EVP & CFO Conference Call Participants Matthew Miksic - Barclays...

NuVasive press release ( NASDAQ: NUVA ): Q4 Non-GAAP EPS of $0.43 misses by $0.08 . Revenue of $305.4M (+1.1% Y/Y) misses by $5.61M . The Company expects 2023 net sales growth of 6%ꟷ8% on an as reported and constant currency basis vs. 5.57% consensus ...